Terns Pharmaceuticals Inc TERN:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
17.13quote price arrow down-1.41 (-7.61%)
Volume
166,951
52 week range
14.83 - 27.44

...

Loading . . .

KEY STATS

  • Open19.89
  • Day High21.00
  • Day Low15.73
  • Prev Close18.54
  • 52 Week High27.44
  • 52 Week High Date03/02/21
  • 52 Week Low14.83
  • 52 Week Low Date02/05/21
  • Market Cap410.61M
  • Shares Out23.97M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-3.02
  • P/E (TTM)-5.67
  • Fwd P/E (NTM)-6.58
  • EBITDA (MRQ)-37.84M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-77.82%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Terns Pharmaceuticals Inc News

There is no recent news for this security.

Latest TERN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Terns Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases. The Company’s NASH pipeline includes multiple single-agent and combination therapy candidates that provide opportunities to address the multifaceted nature of NASH and provide clinical benefits for patients....
Address
1065 East Hillsdale Blvd.
Suite 100, Suite 100
Foster City, CA
94404
United States